If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 29 Mar: World Vaccine Congress highlights IAVI’s R&D from end to end
• 20 Mar: IVCC receives new grant funding from the Australian Government to support vector control innovation across the Indo-Pacific Region
• 24 Mar: Commitment, Innovation and Action are Needed to End TB — On World TB Day, We Reaffirm our Dedication to all Impacted by Tuberculosis
• 25 Mar: Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
• 25 Mar: New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
• 24 Mar: World Tuberculosis Day 2024– We can End TB!
• 12 Mar: GARDP and Google DeepMind collaborate to accelerate target assessment
• 25 Mar: PATH concerned about funding cuts to global health security in US budget deal
• 25 Mar: New partnership aims to improve immunization efforts in conflict-afflicted and under immunized settings
• 17 Apr: Medicines for Malaria Venture appoints new CEO
• 25 Mar: New treatment for relapsing malaria, tafenoquine rolled out in Brazil starting with the Yanomami indigenous people
• 3 Apr: DNDi signs memorandum of understanding with Kenya Medical Research Institute
• 28 Mar: 2023 R&D portfolio in review: HIV
• 28 Mar: 2023 R&D portfolio in review: Hepatitis C
• 28 Mar: 2023 R&D portfolio in review: Sleeping sickness
• 28 Mar: 2023 R&D portfolio in review: Filaria – river blindness
• 28 Mar: 2023 R&D portfolio in review: Dengue
• 28 Mar: 2023 R&D portfolio in review: Pandemic preparedness
• 5 Apr: Global deployment of rapid diagnostic tests to boost fight against cholera
PDP Funder Announcements
• 12 Apr: Ahead of World Chagas Day, Unitaid reiterates its commitment to fighting Chagas disease. Unitaid
• 16 Apr: Unitaid and Expertise France announce the launch of Phase II of the SUCCESS program for the elimination of cervical cancer in ten low-resource countries. Unitaid
• 17 Apr: New Nets Prevent 13 Million Malaria Cases in Sub-Saharan Africa. Unitaid
• 20 Mar: Joint UNFPA-Unitaid venture backed by major EU funding aims to eliminate the leading cause of mothers dying in childbirth in Africa. UNITAID
• 20 Mar: Team Europe and African partners launch four initiatives to strengthen health systems and social protection in Africa. European Commission
• 24 Mar: Investing in the next generation of Tuberculosis treatment. Austrailian Ministry of Foreign Affairs
• 24 Mar: World TB Day 2024: Funding innovative research to end TB. EDCTP
• 27 Mar: Who loses when scientific research is locked behind paywalls?. Bill & Melinda Gates Foundation
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 13 Dec: IVCC’s Annual Report 2022-2023. IVCC
Other Reports/ Publications
• Mar 5: 2023 TB Pipeline Report. TAG
• Mar 14: Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World. GHTC
Related Press Releases/ Announcements/ non-Peer Reviewed Articles
• 1 Apr: 'Pathogen prospecting': Mosquito researchers track malaria's history by examining its epidemiology. MedicalXpress
• 1 Apr: Impact with equity: EDCTP and equitable research partnerships. The Lancet Global Health
• 1 Apr: New report on HIV drug resistance: Challenges and recommendations. News Medical
• 2 Apr: Malaria vaccine rollout shines light on value of renewable power. Reuters
• 2 Apr: Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test?. Health Policy Watch
• 2 Apr: Molecular biology technique allows for discovery of novel targets for candidate vaccines against schistosomiasis. Phys.org
• 2 Apr: From equitable access to equitable innovation: rethinking bioengineering for global health. Nature Bioengineering
• 2 Apr: New malaria vaccine strain shows promise in preclinical trials. News Medical
• 2 Apr: Advances in HIV treatment for adolescents: Are long-acting injectables the future?. Healio
• 2 Apr: Bavarian Nordic announces commercial launch of mpox vaccine. CIDRAP
• 2 Apr: Expanding Access to Long Acting HIV Prevention and Treatment Through Mobile Pharmacies. O’Neil Institute
• 3 Apr: Health As a Driver of Innovation Not Just a Recipient. Health Policy Watch
• 3 Apr: How the next wave of vaccines could target human parasites. Gavi
• 3 Apr: Experimental Ebola vaccines found safe and capable of producing immune responses in healthy adults. NIAID Blog
• 3 Apr: As AI proliferates, biopharma companies seek to harness it in clinical trials. STAT
• 3 Apr: New discovery unravels malaria invasion mechanism. Phys.org
• 3 Apr: Cepheid awarded WHO prequalification for extended coverage of point-of-care HIV test. 360Dx
• 3 Apr: Amid the escalating impact of antimicrobial resistance, the Global Leaders Group calls on UN Member States to take bold and specific action. Global Leaders Group on Antimicrobial Resistance
• 3 Apr: Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low- income and middle-income countries. BMJ Global Health
• 4 Apr: Will the Gates Foundation’s preprint-centric policy help open access?. Nature
• 4 Apr: First-generation malaria vaccine successfully implemented in three African countries. The Lancet
• 4 Apr: Drug prices soar after pharma giants GSK and Sanofi exit Nigeria. Devex
• 4 Apr: Thinking beyond diagnostic accuracy to evaluate tuberculosis screening tests. The Lancet Global Health
• 4 Apr: Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study. The Lancet Global Health
• 4 Apr: Tuberculosis screening in adults with HIV: beyond symptoms. The Lancet Global Health
• 4 Apr: Climate change: A driver of increasing vector-borne disease transmission in non-endemic areas. PLOS Medicine
• 4 Apr: Eight recommendations to shape the future of immunisation. Gavi
• 4 Apr: Tinubu to Gavi CEO: Nigerian manufacturers capable, ready to produce vaccines. Vanguard News
• 5 Mar: New report documents increase in HIV drug resistance to dolutegravir. WHO
• 5 Mar: Dengue is raging in Brazil. A promising local vaccine is at least a year away. Science
• 5 Apr: India’s newly amended patent rules threaten affordable medicines in the Global South. People’s Dispatch
• 5 Apr: Nigerians vaccinated in maiden Lassa fever vaccine clinical trial. The Guardian Nigeria
• 5 Apr: Nigeria needs to create investment environment for vaccine production — GAVI. Nigerian Tribune
• 5 Apr: Developing Countries Call for a Review of the TRIPS Agreement at the WTO. Geneva Health Files
• 5 Apr: To end TB, invest in drug discovery in and for Africa. The Independent Uganda
• 5 Apr: World Health Day: new technologies to accelerate action for global health. Institute of Development Studies
• 6 Mar: After decades of failures, researchers have renewed hopes for an effective HIV vaccine. NBC News
• 6 Mar: Merck-Gilead's weekly HIV combo maintains viral suppression, but it's early days for primary endpoint. Fierce Biotech
• 6 Mar: Long-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed HIV. NIAID
• 7 Mar: New study finds the malaria parasite generates genetic diversity using an evolutionary 'copy-paste' tactic. Phys.org
• 7 Apr: Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance. News Medical
• 7 Mar: Africa CDC announces spate of appointments in wake of deputy departure. Devex
• 7 Mar: What makes a pathogen antibiotic-resistant?. EureakAlert
• 7 Mar: Devex CheckUp: What Africa CDC wants from the pandemic treaty. Devex
• 8 Mar: Chlamydia-like 'parrot fever' won't be the next bird flu pandemic, experts say. BBC
• 8 Apr: UK researchers develop new tuberculosis testing method. 360Dx
• 8 Apr: Inside the push to make intellectual property work for African pharma. Devex
• 8 Apr: GAVI Alliance initiates $1b programme to boost vaccine production in Africa. The Guardian Nigeria
• 9 Apr: AI can help to tailor drugs for Africa — but Africans should lead the way. Nature
• 9 Apr: CEPI talks the need for speed when it comes to equitable vaccine access. BioProcess International
• 9 Apr: Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment. IJHPM
• 9 Apr: Open letter from the biopharmaceutical industry to G20 Ministers in support of the advancement of the G20 Health Agenda. IFPMA
• 10 Apr: New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise. Health Policy Watch
• 10 Apr: Amid Global Cholera Surge, Gavi Launches New Testing Programme. Health Policy Watch
• 10 Apr: Noma is a truly devastating tropical disease – more people need to know about it. Gavi
• 10 Apr: Oxford University and Brazil partner to advance malaria vaccine development. News Medical
• 11 Apr: 'World’s most comprehensive' health database opens to LMIC researchers. Devex
• 11 Apr: Is brain drain limiting Africa’s genomics potential?. Devex
• 11 Apr: Moderna puts plans for African vaccine plant on hold. The Financial Times
• 11 Apr: African Nations Have Agreed A Plan To Increase Locally Produced Vaccines. This Is How It Will Work. Africa.com
• 11 Apr: Exclusive: Concerned About an Unrealistic Deadline to Conclude a Pandemic Agreement, Some Countries Now Seek an Alternative Face-Saving Solution. Geneva Observer
• 11 Apr: Study highlights global rise in drug-resistant priority pathogens. CIDRAP
• 11 Apr: The push for a better dengue vaccine grows more urgent. The New York Times
• 11 Apr: Facing uncertain vaccine demand, Moderna halts mRNA plant buildout in Kenya. Fierce Pharma
• 11 Apr: In world first, Nigeria introduces new 5-in-1 vaccine against meningitis. WHO
• 11 Apr: A new tool for accelerating tuberculosis vaccine development. The Lancet Infectious Diseases
• 13 Apr: Communiqué: United in the Fight Against Mpox in Africa – High-Level Emergency Regional Meeting. Africa CDC
• 14 Apr: USAID awards $45m to advance NTD research. My Joy Online
• 14 Apr: Every year, tuberculosis kills over a million people. Can a new vaccine turn the tide?. Vox
• 14 Mar: How CEPI and its partners are using AI to prepare for 'Disease X'. Devex
• 14 Mar: Study spotlights high incidence of typhoid fever in sub-Saharan Africa. CIDRAP
• 14 Mar: Healthy humans will be deliberately infected with Covid in bid to develop nasal spray vaccine. The Telegraph
• 14 Apr: Breakthrough aerosol human infection model gives hope for future tuberculosis vaccine development. University of Oxford
• 15 Apr: Latest results confirm malaria vaccine in Kenya safe. The Star
• 15 Apr: African-led clinical research needs pharma buy-in. SciDevNet
• 15 Apr: Netherlands and WHO forge stronger partnership in global health agenda. News Medical
• 17 Mar: Why Are African Researchers Left Behind in Global Scientific Publications? – A Viewpoint. IJHPM
• 16 Apr: African-led clinical research essential to tackling the continent's health care challenges, says expert. MedicalXpress
• 16 Apr: World Health Assembly is Likely to See Basic ‘Consensus’ Pandemic Agreement as Hard Decisions are Deferred. Health Policy Watch
• 16 Apr: EXCLUSIVE: Next Draft of The Pandemic Agreement Will Likely Have No Fund and No Binding Obligations On Pathogen Access & Benefits Sharing, Defers Modalities to Conference of Parties. Geneva Health Files
• 16 Apr: New malaria vaccine shows promise: P. falciparum parasite attenuated by dual gene deletion. BioWorld
• 16 Apr: Plans to expand African vaccine production face steep hurdles. Science
• 18 Mar: Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial. The Lancet Infectious Diseases
• 18 Mar: A step forward in the journey towards hookworm vaccines. The Lancet Infectious Diseases
• 18 Mar: Malawi health workers report drop in malaria cases following vaccine intro. GAVI
• 18 Mar: Report: $46 billion US investment in global health generates 'blockbuster returns'. CIDRAP
• 18 Mar: MenFive Vaccine Huge Step Against Meningitis Prevention In Africa – GAVI. Science Nigeria
• 18 Mar: Pioneering Partnerships: The mRNA Technology Transfer Programme Inks Groundbreaking mRNA Vaccine R&D Consortia at Singapore Scientific Colloquium. Medicines Patent Pool
• 19 Mar: $39 to $1 ROI Realized When Deploying Tuberculosis Screening and Prevention. Precision Vaccinations
• 19 Mar: New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites. University of Oxford
• 19 Mar: Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate. Bill & Melinda Gates Medical Research Institute
• 19 Mar: From Mpox to Measles: Are We Living in The Age of Disease Outbreaks?. Health Policy Watch
• 19 Mar: TB shot is in final stage of testing. Politico
• 19 Mar: Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases
• 19 Mar: Scientists say they can cut HIV out of cells. BBC
• 19 Mar: Drug candidate may 'unmask' latent HIV-infected cells, mark them for destruction. MedicalXpress
• 19 Mar: Improving coherence of global research funding: Pandemic PACT. The Lancet
• 19 Mar: High-level event kicks off expansion of strategic EU-AU partnership, pledging joint commitments to strengthen Global Health and African Health Sovereignty. Africa CDC
• 20 Mar: TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention. Health Policy Watch
• 20 Mar: Do you speak market shaping? Reflections from the first Global Health Market shaping conference. MedAccess
• 20 Mar: Innovative use of long-acting injectables holds promise for people with adherence challenges. POZ
• 21 Mar: Everyone wants to stop the next pandemic. But do they want to pay for it?. Devex
• 21 Mar: Local doesn't mean low cost: Serum Institute shares global scale-up plans. Devex
• 21 Mar: Closing diagnostic gaps to achieve parity in women’s healthcare. PLOS Blogs
• 21 Mar: Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity. Health Policy Watch
• 21 Mar: Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing. Health Policy Watch
• 21 Mar: WHO publishes new guidance recommending targeted NGS for drug-resistant TB diagnosis. 360Dx
• 21 Mar: Amidst spreading infectious diseases and climate change, US FDA should renew its focus on neglected tropical diseases. PLOS Neglected Tropical Diseases
• 21 Mar: Are New Tuberculosis Vaccines Really Needed. Precision Vaccinations
• 22 Mar: Pandemic Agreement Talks Stall as Delegates Disagree on Detail. Health Policy Watch
• 22 Mar: France to co-host with African Union and Gavi the launch of the African Vaccine Manufacturing Accelerator (AVMA) and Gavi’s Investment Opportunity for 2026–2030. Gavi
• 22 Mar: Drug-resistant tuberculosis: a persistent global health concern. Nature
• 22 Mar: Ghana sees falling malaria burden, targets elimination. Gavi
• 22 Mar: New global TB dictionary aims to standardize terminology in tuberculosis research. IS Global
• 22 Mar: South African Firm Set to Produce HIV Prevention Ring. Report Focus News
• 22 Mar: Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study. The Lancet Infectious Diseases
• 22 Mar: The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience. The Lancet Infectious Diseases
• 22 Mar: 10 years after the 2014–16 Ebola epidemic in west Africa: advances and challenges in African epidemic preparedness. The Lancet
• 23 Mar: Research in Focus: Gates MRI. The Lancet
• 25 Mar: The right diagnosis for tuberculosis. The Hindu
• 25 Mar: Roche malaria test receives FDA approval. 365Dx
• 25 Mar: World TB Day 2024: Scientists Unveil A Blood Test For Tuberculosis Detection. The Health Site
• 25 Mar: Can We End TB With Financing And Game-Changing Innovations?. The Times of India
• 25 Mar: Five things you need to know about the world’s latest weapon against bacterial meningitis. Gavi
• 25 Mar: Pandemic accord: the key points. MedicalXpress
• 25 Mar: How to Save the Pandemic Treaty. Project Syndicate
• 25 Mar: Long-lasting, injectable HIV prevention drug set for “aggressive” roll-out in Africa. Science
• 25 Mar: Stigma, lack of awareness holding back use of HIV prevention pills, experts say. Spotlight
• 26 Mar: Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models. Globalisation & Health
• 26 Mar: MedAccess welcomes rollout of G6PD testing and tafenoquine in Brazil. MedAccess
• 26 Mar: The emergence of artemisinin partial resistance in Africa: how do we respond?. The Lancet
• 26 Mar: Combination antibiotic gets boost from European regulators. CIDRAP
• 26 Mar: Valneva initiates Phase 1 trial of second-generation Zika vaccine candidate. Valneva
• 26 Mar: The conclusions of the Future of Global Health Initiatives process (Lusaka Agenda): What can we expect?. Aidspan
• 26 Mar: Next phase of TB vaccine clinical trial sparks hope of game-changing results – top SA scientist. Daily Maverick
• 26 Mar: Towards mission-driven investment in new antimicrobials? What role for Chinese strategic industrial financing vehicles in responding to the challenge of antimicrobial resistance?. Globalisation & Health
• 27 Mar: FG to roll out malaria vaccine in Kebbi, Bayelsa. The Guardian Nigeria
• 27 Mar: Artificial intelligence is taking over drug development. The Economist
• 27 Mar: HIV cure nearer with way to 'shock and kill' latent virus. Newsweek
• 27 Mar: Advancing Equity and Innovation in Research Publishing: Time for a New Era in the Open Access Movement?. CGD
• 27 Mar: Worldwide licensing of pandemic technologies is already current practice. The Pandemic Accord should protect it. Medicines Law & Policy
• 27 Mar: Why the mpox outbreak in the Democratic Republic of Congo is worrying disease docs. NPR
• 27 Mar: AU calls for ensuring Africa's self-sufficiency in medicines, vaccines. Xinhua
• 27 Mar: Eyes on Disease X: Ranking the Next Pandemic. Think Global Health
• 27 Mar: WHO launches CoViNet: a global network for coronaviruses. WHO
• 28 Mar: High risk, high reward: Gavi's investment in Africa vaccine production. Devex
• 28 Mar: New Novartis drug aims to tackle parasite resistance to antimalarials. Devex
• 28 Mar: Pandemic (Dis) Agreement Talks Limp into Extra Time. Health Policy Watch
• 28 Mar: WHO Member States agree to resume negotiations aimed at finalizing the world’s first pandemic agreement. WHO
• 29 Mar: Serum Institute’s argument against local manufacturing. Devex
• 30 Mar: How undetected tuberculosis is growing across Africa. Daily Monitor
Upcoming Meetings/ Webinars
--------------------------